A Clinical Update on Antiplatelet Therapy in Secondary Prevention of Ischemic Stroke

被引:0
作者
Katelyn Marsden
Hannah Y. Mak
C. Patrick Crooks
Preethy Pankaj
Thuhien Nguyen
David Tirschwell
机构
[1] University of Washington,Department of Neurology
[2] University of Washington,Department of Pharmacy
来源
Current Cardiology Reports | 2021年 / 23卷
关键词
Ischemic stroke; Secondary prevention; Antiplatelet therapy; Aspirin; Clopidogrel;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 1235 条
[1]  
Feigin VL(2018)Global, regional, and country-specific lifetime risks of stroke, 1990 and 2016 N Engl J Med 379 2429-2437
[2]  
Nguyen G(2020)Heart disease and stroke statistics-2020 update: a report from the American Heart Association Circulation. 141 e139-e596
[3]  
Cercy K(2011)Risk and cumulative risk of stroke recurrence: a systematic review and meta-analysis Stroke. 42 1489-1494
[4]  
Johnson CO(2014)Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association Stroke. 45 2160-2236
[5]  
Alam T(1997)International Stroke Trial Collaborative Group Lancet 349 1569-1581
[6]  
Virani SS(1997)CAST (Chinese Acute Stroke Trial) Collaborative Group Lancet 349 1641-1649
[7]  
Alonso A(2009)Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials Lancet. 373 1849-1860
[8]  
Benjamin EJ(2018)2018 Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association Stroke. 49 e46-e110
[9]  
Bittencourt MS(2002)Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients BMJ. 324 71-86
[10]  
Callaway CW(2006)Aspirin resistance Lancet. 367 606-617